KalVista Pharmaceuticals, Inc.
← Back to KALV Overview

KalVista Pharmaceuticals, Inc. (KALV)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-37.98

Financial Fundamentals

KALVQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2013-12-31-11.69
2014-03-31-7.00
2014-06-30-5.35
2014-09-30-3.53
2014-12-31-2.99
2015-03-31-4.39
2015-06-30-4.49
2015-09-30-4.71
2015-12-31-4.21
2016-03-31-0.64
2016-06-30-4.68
2016-09-30
2017-01-31-1.76
2017-04-30-4.19
2017-07-31-3.57
2017-10-31-6.39
2018-01-31-5.38
2018-04-30-39.52
2018-07-31-5.03
2018-10-31-21.61
2019-01-31-20.35
2019-04-30-11.59
2019-07-31-9.88
2019-10-31-8.00
2020-01-31-7.34
2020-04-30-7.39
2020-07-31-4.06
2020-10-31-7.39
2021-01-31-6.79
2021-04-30-9.46
2021-07-31-7.64
2021-10-31-5.67
2022-01-31-3.44
2022-04-30-3.24
2022-07-31-3.25
2022-10-31-1.40
2023-01-31-2.64
2023-04-30-2.90
2023-07-31-3.43
2023-10-31-2.65
2024-01-31-4.72
2024-04-30-2.77
2024-07-31-4.16
2024-10-31-2.84
2025-01-31-2.42
2025-04-30-3.27
2025-07-31-3.03
2025-09-30-3.32
2025-12-31-37.98

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.